Ethical assessment of industry-sponsored clinical trials: a case analysis.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 11948071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The rapid growth of clinical trials sponsored by the pharmaceutical industry and conducted by community physicians raises concerns about the scientific quality of this research and the adequacy of protections for research participants. In this article, we present an in-depth ethical analysis of a recent industry-sponsored placebo-controlled study for treatment of asthma. The ethical analysis uses a proposed ethical framework for evaluating clinical research focusing on seven ethical requirements: (1) scientific value, (2) scientific validity, (3) fair subject selection, (4) favorable risk/benefit ratio, (5) independent review, (6) informed consent, and (7) respect for enrolled subjects.
Medical subject headings
- Asthma
- Beclomethasone
- Conflict of Interest
- Controlled Clinical Trials as Topic
- Drug Industry
- Ethics, Medical
- Patient Selection
- Pregnadienediols
- Research Support as Topic